2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Deep brain stimulation in three patients with dystonia and severe cerebellar atrophy

V. Gonzalez, L. Cif, E. Sanrey, E. Nerrant, F. Cyprien, M. Ros, E. Chanseng, T. Roujeau, P. Coubes (Montpellier, France)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Deep brain stimulation of the locomotor mesencephalic region in rats with lesioned sensorimotor cortex: A model of functional motor recovery after stroke

F. Fluri, M.K. Schuhmann, C. Kleinschnitz, J. Volkmann (Würzburg, Germany)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Detailed evaluation of dyskinesias using multiple endpoints in a randomized, placebo-controlled trial of Parkinson’s disease patients with motor fluctuations

C. Kenney, K. Kieburtz, W. Olanow, S. Bandak (San Francisco, CA, USA)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Development of a human neuroblastoma model of pantothenate kinase-associated neurodegeneration

A. Di Marco, G. Auciello, A. Vecchi, D. Vignone, M.R. Battista, E. Bracacel, F. Bonelli, E. Nizi, E. Monteagudo, M. Beconi (Pomezia, Italy)

Parkinson's Disease: Clinical Trials II and Non-PD Clinical Trials

12:00pm-1:30pm

Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model

P.C. Bhatt, V. Kumar (New Delhi, India)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Development of a nanoherbaceutical formulation containing compound extracts from huperzia serrata, mucuna pruriens and withania somnifera for the prevention and treatment of Parkinson’s disease

V. Kumar, P.C. Bhatt (Allahabad, India)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Development of hyperkinesias after long term pallidal stimulation for dystonia

A. Wloch, G. Lütjens, C. Schrader, M. Manu, C. Blahak, J.K. Krauss (Hannover, Germany)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Diagnostic value of a new coronal examination plane in transcranial nigral sonography and of additional M-mode tremor frequency determination for the differentiation of idiopathic Parkinson’s disease and essential tremor

L. Tönges, R. Daniel, D. Woitalla, S. Muhlack, R. Gold, C. Krogias (Bochum, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Diaphragmatic dystonia in a patient that presents with Meige syndrome and disordered breathing

N. Licking, B. Farro (Portland, OR, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe

A.L. Molinari, H.L. Gewanter, M. Reilly, D. Charles (Washington, DC, USA)

Other  ·  Exhibit Hall located in Hall B, Level 2